TZD18 is a potent and orally active PPARalpha and PPARgamma dual agonist with IC50 values of 0.028, 0.057, >10 µM for PPARalpha, PPARgamma, PPARdelta, respectively. TZD18 reduces plasma levels of both glucose and triglycerides in diabetic mice. TZD18 has the potential for the research of type 2 diabetes[1].
Molecular Weight:
477.57
CAS Number:
[228577-00-2]
Formula:
C27H27NO5S
Target:
PPAR
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
